{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,5]],"date-time":"2026-05-05T17:09:33Z","timestamp":1778000973502,"version":"3.51.4"},"reference-count":48,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"publisher","award":["APP1091261"],"award-info":[{"award-number":["APP1091261"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"publisher","award":["APP1119152"],"award-info":[{"award-number":["APP1119152"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"publisher","award":["APP1157871"],"award-info":[{"award-number":["APP1157871"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001102","name":"Cancer Council NSW","doi-asserted-by":"publisher","award":["PG16-01"],"award-info":[{"award-number":["PG16-01"]}],"id":[{"id":"10.13039\/501100001102","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001171","name":"Cancer Institute NSW","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001171","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["FR 854\/8-1"],"award-info":[{"award-number":["FR 854\/8-1"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001773","name":"University of New South Wales","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001773","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100018896","name":"Kids Cancer Alliance","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100018896","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Biological Macromolecules"],"published-print":{"date-parts":[[2024,1]]},"DOI":"10.1016\/j.ijbiomac.2023.127596","type":"journal-article","created":{"date-parts":[[2023,10,27]],"date-time":"2023-10-27T00:11:05Z","timestamp":1698365465000},"page":"127596","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"special_numbering":"P1","title":["An antibody fragment-decorated liposomal conjugate targets Philadelphia-like acute lymphoblastic leukemia"],"prefix":"10.1016","volume":"254","author":[{"given":"Sara M.A.","family":"Mohamed","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter","family":"Schofield","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hannah","family":"McCalmont","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ernest","family":"Moles","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Karl-Heinz","family":"Friedrich","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria","family":"Kavallaris","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniel","family":"Christ","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Narges","family":"Bayat","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Richard B.","family":"Lock","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijbiomac.2023.127596_bb0005","doi-asserted-by":"crossref","first-page":"2064","DOI":"10.1182\/blood-2017-06-743252","article-title":"Philadelphia chromosome\u2013like acute lymphoblastic leukemia","volume":"130","author":"Tasian","year":"2017","journal-title":"Blood"},{"key":"10.1016\/j.ijbiomac.2023.127596_bb0010","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1002\/pbc.26188","article-title":"The relationship between cognitive and neuroimaging outcomes in children treated for acute lymphoblastic leukemia with chemotherapy only: a systematic review","volume":"64","author":"Hearps","year":"2017","journal-title":"Pediatr. Blood Cancer"},{"key":"10.1016\/j.ijbiomac.2023.127596_bb0015","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1080\/17425255.2017.1351547","article-title":"Chemotherapy-induced cardiotoxicity in children","volume":"13","author":"Bansal","year":"2017","journal-title":"Expert Opin. Drug Metab. Toxicol."},{"issue":"5","key":"10.1016\/j.ijbiomac.2023.127596_bb0020","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1111\/ejh.12862","article-title":"Inotuzumab ozogamicin in relapsed B-cell acute lymphoblastic leukemia","volume":"98","author":"Thota","year":"2017","journal-title":"Eur. J. Haematol."},{"issue":"7","key":"10.1016\/j.ijbiomac.2023.127596_bb0025","doi-asserted-by":"crossref","first-page":"1795","DOI":"10.1158\/1078-0432.CCR-12-3613","article-title":"The anti-CD19 antibody\u2013drug conjugate SAR3419 prevents hematolymphoid relapse postinduction therapy in preclinical models of pediatric acute lymphoblastic leukemia","volume":"19","author":"Carol","year":"2013","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.ijbiomac.2023.127596_bb0030","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1182\/blood-2014-11-612903","article-title":"Eradication of B-ALL using chimeric antigen receptor\u2013expressing T cells targeting the TSLPR oncoprotein","volume":"126","author":"Qin","year":"2015","journal-title":"Blood"},{"issue":"11","key":"10.1016\/j.ijbiomac.2023.127596_bb0035","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1182\/blood.2019002132","article-title":"How I treat adults with advanced acute lymphoblastic leukemia eligible for CD19-targeted immunotherapy","volume":"135","author":"Aldoss","year":"2020","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.ijbiomac.2023.127596_bb0040","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/2162-3619-1-36","article-title":"CD19: a biomarker for B cell development, lymphoma diagnosis and therapy","volume":"1","author":"Wang","year":"2012","journal-title":"Exp. Hematol. Oncol."},{"issue":"26","key":"10.1016\/j.ijbiomac.2023.127596_bb0045","doi-asserted-by":"crossref","first-page":"5312","DOI":"10.1182\/blood-2009-09-245944","article-title":"Rearrangement of CRLF2 is associated with mutation of JAK kinases, alteration of IKZF1, Hispanic\/Latino ethnicity, and a poor outcome in pediatric B-progenitor acute lymphoblastic leukemia","volume":"115","author":"Harvey","year":"2010","journal-title":"Blood"},{"issue":"13","key":"10.1016\/j.ijbiomac.2023.127596_bb0050","doi-asserted-by":"crossref","first-page":"2688","DOI":"10.1182\/blood-2009-03-208397","article-title":"Deregulated expression of cytokine receptor gene, CRLF2, is involved in lymphoid transformation in B-cell precursor acute lymphoblastic leukemia","volume":"114","author":"Russell","year":"2009","journal-title":"Blood"},{"issue":"11","key":"10.1016\/j.ijbiomac.2023.127596_bb0055","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1056\/NEJMoa1403088","article-title":"Targetable kinase-activating lesions in Ph-like acute lymphoblastic leukemia","volume":"371","author":"Roberts","year":"2014","journal-title":"N. Engl. J. Med."},{"issue":"45","key":"10.1016\/j.ijbiomac.2023.127596_bb0060","doi-asserted-by":"crossref","first-page":"19455","DOI":"10.1073\/pnas.1008271107","article-title":"Thymic stromal lymphopoietin-mediated STAT5 phosphorylation via kinases JAK1 and JAK2 reveals a key difference from IL-7\u2013induced signaling","volume":"107","author":"Rochman","year":"2010","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"issue":"2\/3","key":"10.1016\/j.ijbiomac.2023.127596_bb0065","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1515\/bc.2010.029","article-title":"Signal transduction by the atopy-associated human thymic stromal lymphopoietin (TSLP) receptor depends on Janus kinase function","volume":"391","author":"Wohlmann","year":"2010","journal-title":"Biol. Chem."},{"key":"10.1016\/j.ijbiomac.2023.127596_bb0070","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1016\/j.ijbiomac.2021.08.194","article-title":"A recombinant antibody fragment directed to the thymic stromal lymphopoietin receptor (CRLF2) efficiently targets pediatric Philadelphia chromosome-like acute lymphoblastic leukemia","volume":"190","author":"Mohamed","year":"2021","journal-title":"Int. J. Biol. Macromol."},{"issue":"1","key":"10.1016\/j.ijbiomac.2023.127596_bb0075","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s11671-021-03553-8","article-title":"Liposomal nanomedicine: applications for drug delivery in cancer therapy","volume":"16","author":"Rommasi","year":"2021","journal-title":"Nanoscale Res. Lett."},{"issue":"7","key":"10.1016\/j.ijbiomac.2023.127596_bb0080","doi-asserted-by":"crossref","first-page":"2023","DOI":"10.1016\/j.nano.2018.05.021","article-title":"Lipid based nanocarriers: a translational perspective","volume":"14","author":"Mishra","year":"2018","journal-title":"Nanomedicine: Nanotechnology, Biology and Medicine"},{"key":"10.1016\/j.ijbiomac.2023.127596_bb0085","article-title":"Advances in liposomal drug delivery to cancer: an overview","volume":"56","author":"Saraf","year":"2020","journal-title":"J. Drug Deliv. Sci. Technol."},{"issue":"1","key":"10.1016\/j.ijbiomac.2023.127596_bb0090","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/17425247.2017.1262346","article-title":"Cancer nanomedicines: oversold or underappreciated?","volume":"14","author":"van der Meel","year":"2017","journal-title":"Expert Opin. Drug Deliv."},{"issue":"9","key":"10.1016\/j.ijbiomac.2023.127596_bb0095","doi-asserted-by":"crossref","first-page":"2685","DOI":"10.1158\/1078-0432.CCR-18-2990","article-title":"FDA approval summary:(daunorubicin and cytarabine) liposome for injection for the treatment of adults with high-risk acute myeloid leukemia","volume":"25","author":"Krauss","year":"2019","journal-title":"Clin. Cancer Res."},{"issue":"7","key":"10.1016\/j.ijbiomac.2023.127596_bb0100","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1634\/theoncologist.2015-0391","article-title":"Efficacy and safety of vincristine sulfate liposome injection in the treatment of adult acute lymphocytic leukemia","volume":"21","author":"Douer","year":"2016","journal-title":"Oncologist"},{"issue":"1","key":"10.1016\/j.ijbiomac.2023.127596_bb0105","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1039\/C6SC02403C","article-title":"Antibody fragments as nanoparticle targeting ligands: a step in the right direction","volume":"8","author":"Richards","year":"2017","journal-title":"Chem. Sci."},{"key":"10.1016\/j.ijbiomac.2023.127596_bb0110","series-title":"Monoclonal Antibodies","first-page":"315","article-title":"Reformatting of scFv antibodies into the scFv-Fc format and their downstream purification","author":"Bujak","year":"2014"},{"issue":"8","key":"10.1016\/j.ijbiomac.2023.127596_bb0115","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1158\/1535-7163.MCT-20-0565","article-title":"ASN004, a 5T4-targeting scFv-fc antibody-drug conjugate with high drug-to-antibody ratio, induces complete and durable tumor regressions in preclinical models","volume":"20","author":"Smith","year":"2021","journal-title":"Mol. Cancer Ther."},{"issue":"10","key":"10.1016\/j.ijbiomac.2023.127596_bb0120","doi-asserted-by":"crossref","first-page":"2689","DOI":"10.1158\/1535-7163.MCT-10-0644","article-title":"Maytansine and cellular metabolites of antibody-maytansinoid conjugates strongly suppress microtubule dynamics by binding to microtubules","volume":"9","author":"Lopus","year":"2010","journal-title":"Mol. Cancer Ther."},{"issue":"6","key":"10.1016\/j.ijbiomac.2023.127596_bb0125","doi-asserted-by":"crossref","first-page":"1704","DOI":"10.1016\/j.celrep.2013.11.020","article-title":"An optimized microRNA backbone for effective single-copy RNAi","volume":"5","author":"Fellmann","year":"2013","journal-title":"Cell Rep."},{"issue":"11","key":"10.1016\/j.ijbiomac.2023.127596_bb0130","doi-asserted-by":"crossref","first-page":"4100","DOI":"10.1182\/blood.V99.11.4100","article-title":"The nonobese diabetic\/severe combined immunodeficient (NOD\/SCID) mouse model of childhood acute lymphoblastic leukemia reveals intrinsic differences in biologic characteristics at diagnosis and relapse","volume":"99","author":"Lock","year":"2002","journal-title":"Blood"},{"key":"10.1016\/j.ijbiomac.2023.127596_bb0135","doi-asserted-by":"crossref","first-page":"9795","DOI":"10.2147\/IJN.S220326","article-title":"Thiol-reactive star polymers functionalized with short ethoxy-containing moieties exhibit enhanced uptake in acute lymphoblastic leukemia cells","volume":"14","author":"Bayat","year":"2019","journal-title":"Int. J. Nanomedicine"},{"key":"10.1016\/j.ijbiomac.2023.127596_bb0140","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/j.biomaterials.2017.08.020","article-title":"ImmunoPEGliposomes for the targeted delivery of novel lipophilic drugs to red blood cells in a falciparum malaria murine model","volume":"145","author":"Moles","year":"2017","journal-title":"Biomaterials"},{"issue":"1","key":"10.1016\/j.ijbiomac.2023.127596_bb0145","doi-asserted-by":"crossref","first-page":"39","DOI":"10.3390\/pharmaceutics11010039","article-title":"Comparative analysis of protein quantification methods for the rapid determination of protein loading in liposomal formulations","volume":"11","author":"Hussain","year":"2019","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.ijbiomac.2023.127596_bb0150","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1126\/science.2911722","article-title":"Structural origins of high-affinity biotin binding to streptavidin","volume":"243","author":"Weber","year":"1989","journal-title":"Science"},{"issue":"24","key":"10.1016\/j.ijbiomac.2023.127596_bb0155","doi-asserted-by":"crossref","first-page":"5779","DOI":"10.1007\/s00216-017-0527-z","article-title":"Zeta potential: a case study of cationic, anionic, and neutral liposomes","volume":"409","author":"Smith","year":"2017","journal-title":"Anal. Bioanal. Chem."},{"issue":"6","key":"10.1016\/j.ijbiomac.2023.127596_bb0160","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1016\/j.cell.2012.02.034","article-title":"Antibody-based immunotherapy of cancer","volume":"148","author":"Weiner","year":"2012","journal-title":"Cell"},{"issue":"4","key":"10.1016\/j.ijbiomac.2023.127596_bb0165","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1038\/nrc3236","article-title":"Antibody therapy of cancer","volume":"12","author":"Scott","year":"2012","journal-title":"Nat. Rev. Cancer"},{"issue":"15","key":"10.1016\/j.ijbiomac.2023.127596_bb0170","doi-asserted-by":"crossref","first-page":"6300","DOI":"10.1158\/0008-5472.CAN-08-0461","article-title":"Differential cellular internalization of anti-CD19 and-CD22 immunotoxins results in different cytotoxic activity","volume":"68","author":"Du","year":"2008","journal-title":"Cancer Res."},{"issue":"4","key":"10.1016\/j.ijbiomac.2023.127596_bb0175","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1007\/s40259-013-0016-7","article-title":"Targeting CD22 in B-cell malignancies: current status and clinical outlook","volume":"27","author":"Sullivan-Chang","year":"2013","journal-title":"BioDrugs"},{"issue":"4","key":"10.1016\/j.ijbiomac.2023.127596_bb0180","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1002\/ppsc.201200125","article-title":"Anti-CRLF2 antibody-armored biodegradable nanoparticles for childhood B-ALL","volume":"30","author":"Raghunathan","year":"2013","journal-title":"Part. Part. Syst. Charact."},{"issue":"1","key":"10.1016\/j.ijbiomac.2023.127596_bb0185","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1556-276X-8-102","article-title":"Liposome: classification, preparation, and applications","volume":"8","author":"Akbarzadeh","year":"2013","journal-title":"Nanoscale Res. Lett."},{"issue":"2","key":"10.1016\/j.ijbiomac.2023.127596_bb0190","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/S0005-2736(97)00126-0","article-title":"Toxicity and immunomodulatory activity of liposomal vectors formulated with cationic lipids toward immune effector cells","volume":"1329","author":"Filion","year":"1997","journal-title":"Biochimica et Biophysica Acta (BBA)-Biomembranes"},{"issue":"2","key":"10.1016\/j.ijbiomac.2023.127596_bb0195","doi-asserted-by":"crossref","first-page":"190","DOI":"10.3390\/nano10020190","article-title":"Immunological and toxicological considerations for the design of liposomes","volume":"10","author":"Inglut","year":"2020","journal-title":"Nanomaterials"},{"issue":"5","key":"10.1016\/j.ijbiomac.2023.127596_bb0200","doi-asserted-by":"crossref","first-page":"1325","DOI":"10.1021\/acs.molpharmaceut.6b01027","article-title":"Lipid\u2013drug conjugate for enhancing drug delivery","volume":"14","author":"Irby","year":"2017","journal-title":"Mol. Pharm."},{"issue":"1","key":"10.1016\/j.ijbiomac.2023.127596_bb0205","first-page":"1","article-title":"In vivo cation exchange in quantum dots for tumor-specific imaging","volume":"8","author":"Liu","year":"2017","journal-title":"Nat. Commun."},{"issue":"23","key":"10.1016\/j.ijbiomac.2023.127596_bb0210","doi-asserted-by":"crossref","first-page":"5672","DOI":"10.3390\/molecules25235672","article-title":"Recent progress in bioconjugation strategies for liposome-mediated drug delivery","volume":"25","author":"Almeida","year":"2020","journal-title":"Molecules"},{"key":"10.1016\/j.ijbiomac.2023.127596_bb0215","series-title":"Recombinant Glycoprotein Production","first-page":"229","article-title":"Preparation of immunoliposomes by direct coupling of antibodies based on a thioether bond","author":"Petrilli","year":"2018"},{"key":"10.1016\/j.ijbiomac.2023.127596_bb0220","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.biomaterials.2017.11.029","article-title":"Targeted drug delivery for tumor therapy inside the bone marrow","volume":"155","author":"Mu","year":"2018","journal-title":"Biomaterials"},{"issue":"2","key":"10.1016\/j.ijbiomac.2023.127596_bb0225","doi-asserted-by":"crossref","first-page":"57","DOI":"10.3390\/pharmaceutics10020057","article-title":"Impact of particle size and polydispersity index on the clinical applications of lipidic nanocarrier systems","volume":"10","author":"Danaei","year":"2018","journal-title":"Pharmaceutics"},{"issue":"10","key":"10.1016\/j.ijbiomac.2023.127596_bb0230","doi-asserted-by":"crossref","first-page":"3905","DOI":"10.1182\/blood-2003-08-2911","article-title":"Characterization of childhood acute lymphoblastic leukemia xenograft models for the preclinical evaluation of new therapies","volume":"103","author":"Liem","year":"2004","journal-title":"Blood"},{"issue":"6","key":"10.1016\/j.ijbiomac.2023.127596_bb0235","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1038\/nrclinonc.2012.61","article-title":"Patient-derived tumour xenografts as models for oncology drug development","volume":"9","author":"Tentler","year":"2012","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"10.1016\/j.ijbiomac.2023.127596_bb0240","series-title":"MAbs","article-title":"Implications of receptor-mediated endocytosis and intracellular trafficking dynamics in the development of antibody drug conjugates","author":"Ritchie","year":"2013"}],"container-title":["International Journal of Biological Macromolecules"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S014181302304494X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S014181302304494X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,10,31]],"date-time":"2024-10-31T14:20:22Z","timestamp":1730384422000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S014181302304494X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1]]},"references-count":48,"alternative-id":["S014181302304494X"],"URL":"https:\/\/doi.org\/10.1016\/j.ijbiomac.2023.127596","relation":{},"ISSN":["0141-8130"],"issn-type":[{"value":"0141-8130","type":"print"}],"subject":[],"published":{"date-parts":[[2024,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"An antibody fragment-decorated liposomal conjugate targets Philadelphia-like acute lymphoblastic leukemia","name":"articletitle","label":"Article Title"},{"value":"International Journal of Biological Macromolecules","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijbiomac.2023.127596","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"127596"}}